MELAS and MERRF - The relationship between maternal mutation load and the frequency of clinically affected offspring

被引:76
作者
Chinnery, PE
Howell, N
Lightowlers, RN
Turnbull, DM
机构
[1] Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77550 USA
基金
英国惠康基金;
关键词
mitochondrial encephalomyopathies; MELAS; MERRF; mitochondrial inheritance; maternal inheritance;
D O I
10.1093/brain/121.10.1889
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The majority of pathogenic mitochondrial DNA (mtDNA) mutations are heteroplasmic, with both mutant and wildtype alleles present within the same individual. MtDNA is transmitted only from females to their offspring but a single female can bear offspring who harbour different levels of mutant mtDNA and have a variable phenotype, In single families, this complex genetic and phenotypic variability has confounded the identification of any relationship between the level of mutant mtDNA (mutation load) in the mother and the clinical features of her offspring. To obtain a more accurate description of the inheritance of pathogenic mtDNA mutations, we studied a large number of pedigrees that carried either the mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (A3243G MELAS) or the myoclonic epilepsy with ragged-red fibres (A8344G MERRF) mutations. We made two principal observations. First, for both mutations, higher levels of mutant mtDNA in the mothers' blood were associated with an increased frequency of affected offspring. Secondly, at any one level of maternal mutation load there was a greater frequency of affected offspring for the A3243G MELAS mutation than for the A8344G MERRF mutation. Although these results should not be used to give absolute risks to a female contemplating pregnancy, they suggest that the outcome of pregnancy is related to the level of mutant mtDNA in the mother and that the risks of having affected offspring may differ between different mtDNA mutations.
引用
收藏
页码:1889 / 1894
页数:6
相关论文
共 50 条
[1]  
Altman DG, 1990, PRACTICAL STAT MED R
[2]   COMPLEMENTATION AND SEGREGATION BEHAVIOR OF DISEASE-CAUSING MITOCHONDRIAL-DNA MUTATIONS IN CELLULAR-MODEL SYSTEMS [J].
ATTARDI, G ;
YONEDA, M ;
CHOMYN, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1271 (01) :241-248
[3]  
CAMPOS Y, 1995, ACTA NEUROL SCAND, V91, P62
[4]   Clinical features, investigation, and management of patients with defects of mitochondrial DNA [J].
Chinnery, PF ;
Turnbull, DM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (05) :559-563
[5]   Mitochondrial medicine [J].
Chinnery, PF ;
Turnbull, DM .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1997, 90 (11) :657-667
[6]   Molecular pathology of MELAS and MERRF - The relationship between mutation load and clinical phenotypes [J].
Chinnery, PF ;
Howell, N ;
Lightowlers, RN ;
Turnbull, DM .
BRAIN, 1997, 120 :1713-1721
[7]   INVITRO GENETIC TRANSFER OF PROTEIN-SYNTHESIS AND RESPIRATION DEFECTS TO MITOCHONDRIAL DNA-LESS CELLS WITH MYOPATHY-PATIENT MITOCHONDRIA [J].
CHOMYN, A ;
MEOLA, G ;
BRESOLIN, N ;
LAI, ST ;
SCARLATO, G ;
ATTARDI, G .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (04) :2236-2244
[8]  
CHU NS, 1994, MUSCLE NERVE, V17, P1230
[9]   MELAS - CLINICAL-FEATURES, BIOCHEMISTRY, AND MOLECULAR-GENETICS [J].
CIAFALONI, E ;
RICCI, E ;
SHANSKE, S ;
MORAES, CT ;
SILVESTRI, G ;
HIRANO, M ;
SIMONETTI, S ;
ANGELINI, C ;
DONATI, MA ;
GARCIA, C ;
MARTINUZZI, A ;
MOSEWICH, R ;
SERVIDEI, S ;
ZAMMARCHI, E ;
BONILLA, E ;
DEVIVO, DC ;
ROWLAND, LP ;
SCHON, EA ;
DIMAURO, S .
ANNALS OF NEUROLOGY, 1992, 31 (04) :391-398
[10]  
Daly L. E., 1991, INTERPRETATION USES